Global /United States /Industrials /Specialty Business Services /NASC
chevron_leftBack
Nascent Pharma Holdings, Inc. logo

Nascent Pharma Holdings, Inc.

NASC
OTCMKTS: NASC Delayed
0.0154USD 7.3%
As of 18 June 2026, Nascent Pharma Holdings, Inc. has a market cap of $2.06M USD, ranking #47208 globally and #5993 in the United States. It ranks #10706 in the Industrials sector, and #1438 in the Specialty Business Services industry.
Global Rank
47208
Country Rank
5993
Sector Rank
10706
Industry Rank
1438
Key Stats
Market Cap
$2.06MUSD
Enterprise Value
$19.29MUSD
Revenue (TTM)
$1.03MUSD
EBITDA (TTM)
-$6.78MUSD
Net Income (TTM)
-$13.26MUSD
PS Ratio
2.0
PB Ratio
-0.2
Company Profile
Country (HQ)
Sector
Industrials
Industry
Specialty Business Services
CEO
Marco Alfonsi open_in_new
Employees
12
Founded
2005
Website
nascentpharmaholdings.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
7.3% -4.1% 23% -36% -32% -75%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
NASC
Nascent Pharma Holdings Inc
ISIN: US63108T1051
Shares Out.:
75.842M1 Shares Float: 73.309M2
TV:
SA:
YF:
GF:
BA:
MS:
0.0154 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Nascent Pharma Holdings, Inc.

Nascent Pharma Holdings, Inc. engages in the protection and commercialization of cannabis patents. It produces superfood drink mix products under the Longevity brand name. The company was formerly known as Can B Corp. and changed its name to Nascent Pharma Holdings, Inc. in September 2025. Nascent Pharma Holdings, Inc. was incorporated in 2005 and is based in Hicksville, New York.

Similar Companies

Industry: Specialty Business Services (United States)
Name
Market Cap diff.
PE
CTAS
$69.6B
3M%
36.8
PYPL
$45.83B
2M%
9.4
XYZ
$41.37B
2M%
33.1
FISV
$33.06B
2M%
9.8
ROL
$26.64B
1M%
51.1
CPAY
$20.3B
985K%
20.7
Industry: Specialty Business Services (Global)
Name
Market Cap diff.
PE
SHOP
$158.14B
8M%
129.8
VSURE
$132.46B
114.8B EUR
6M%
-
REL
$63.49B
47.6B GBP
3M%
23.9
$41.8B
56.91B CAD
2M%
-
$41.06B
35.58B EUR
2M%
23.4
ADYEN
$34.73B
30.1B EUR
2M%
28.4
chevron_leftBack